Request Deal Involvement
Carlyle and Atmas Health completed the acquisition of the Vantive kidney care segment of Baxter for $3.8bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
CMS
financial advisors
Goldman Sachs
legal advisors
Kirkland & Ellis
financial advisors
Barclays
financial advisors
JP Morgan
financial advisors
Perella Weinberg Partners
legal advisors
Sullivan & Cromwell
legal advisors
Baker McKenzie
legal advisors
White & Case
legal advisors
Trench Rossi e Watanabe
or
Principals
target
VANTIVE (BAXTER KIDNEY CARE SEGMENT)
bidder
THE CARLYLE GROUP
vendor
BAXTER INTERNATIONAL INC
bidder
ATMAS HEALTH
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite